Filling the gap in CNS drug development: evaluation of the role of drug repurposing
Background and objective: Background and objective: Drug repurposing has been considered a cost-effective and reduced-risk strategy for developing new drugs. Little is known and documented regarding the efficiency of repurposing strategies in drug development. The objective of this article is to ass...
Saved in:
| Main Authors: | A. Caban, K. Pisarczyk, K. Kopacz, A. Kapuśniak, M. Toumi, C. Rémuzat, A. Kornfeld |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2017-01-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20016689.2017.1299833 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Repurposing for Rare Orphan Diseases Using Machine Learning Techniques
by: Rajesh Manicavasaga, et al.
Published: (2022-05-01) -
Repurposing drugs: Lessons from rheumatology in the COVID-19 pandemic
by: Manesh Manoj, et al.
Published: (2021-01-01) -
Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives
by: Zixun Wang, et al.
Published: (2025-03-01) -
Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter
by: Teresa Pacifico, et al.
Published: (2025-07-01) -
IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials
by: Jihan K. Zaki, et al.
Published: (2025-03-01)